• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国镰状细胞病危重症患者的趋势、预测因素及预后

Trends, Predictors, and Outcomes of Critically Ill Patients With Sickle Cell Disease in the United States.

作者信息

Nzeako Tochukwu, Adeniran Olayemi, Kaur Saranjeet, Singh Shreya, Wang Jen, Alzoubi Ammar

机构信息

Department of Internal Medicine Christiana Care Hospital Newark Delaware USA.

Department of Cardiovascular Diseases SUNY Downstate Health Sciences University Brooklyn New York USA.

出版信息

EJHaem. 2025 Aug 13;6(4):e70111. doi: 10.1002/jha2.70111. eCollection 2025 Aug.

DOI:10.1002/jha2.70111
PMID:40809952
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12345595/
Abstract

INTRODUCTION

Despite recent advances in sickle cell disease (SCD) research and management, there remains very limited information available on critically ill SCD patients requiring intensive care units (ICUs).

METHODS

The National Inpatient Sample was queried using the International Classification of Diseases codes to identify critically ill patients with SCD requiring ICU admission. These patients were further stratified into those with and without adverse clinical events (ACEs). The study outcomes were the incidence of acute chest syndrome, cardiac arrest, hemodialysis, sepsis, shock, and transfusion.

RESULTS

Of 5941 patients admitted to the ICU, 2826 (47.6%) had ACE. Patients with ACE were likely to be older, male, white, rural, and have higher comorbidities. The prevalence of ICU admission increased by 126% ( < 0.01). The predictors of ACE included male sex, older age, coronary artery disease, heart failure, renal failure, and two or more comorbidities. Patients with ACE were more likely to have cardiac arrest, hemodialysis, sepsis, and shock (all < 0.01).

CONCLUSION

There has been an increase in the prevalence of critically ill SCD patients requiring ICU care, with subsequent morbidity and mortality. Further research is needed to understand the underlying factors that drive these observed trends and increase mortality rates.

TRIAL REGISTRATION

The authors have confirmed clinical trial registration is not needed for this submission.

摘要

引言

尽管镰状细胞病(SCD)的研究和管理最近取得了进展,但关于需要重症监护病房(ICU)的重症SCD患者的可用信息仍然非常有限。

方法

使用国际疾病分类代码查询全国住院患者样本,以识别需要入住ICU的重症SCD患者。这些患者进一步分为有和没有不良临床事件(ACE)的患者。研究结果包括急性胸综合征、心脏骤停、血液透析、败血症、休克和输血的发生率。

结果

在入住ICU的5941名患者中,2826名(47.6%)发生了ACE。发生ACE的患者可能年龄较大、为男性、白人、居住在农村且合并症较多。入住ICU的患病率增加了126%(<0.01)。ACE的预测因素包括男性、年龄较大、冠状动脉疾病、心力衰竭、肾衰竭以及两种或更多种合并症。发生ACE的患者更有可能发生心脏骤停、血液透析、败血症和休克(均<0.01)。

结论

需要ICU护理的重症SCD患者的患病率有所增加,随之而来的是发病率和死亡率上升。需要进一步研究以了解导致这些观察到的趋势和增加死亡率的潜在因素。

试验注册

作者已确认本提交不需要临床试验注册。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f10/12345595/8f0615641fc6/JHA2-6-e70111-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f10/12345595/8f0615641fc6/JHA2-6-e70111-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f10/12345595/8f0615641fc6/JHA2-6-e70111-g001.jpg

相似文献

1
Trends, Predictors, and Outcomes of Critically Ill Patients With Sickle Cell Disease in the United States.美国镰状细胞病危重症患者的趋势、预测因素及预后
EJHaem. 2025 Aug 13;6(4):e70111. doi: 10.1002/jha2.70111. eCollection 2025 Aug.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].[容量与健康结果:来自系统评价和意大利医院数据评估的证据]
Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100.
4
Hydroxyurea (hydroxycarbamide) for sickle cell disease.羟基脲(羟脲)治疗镰状细胞病。
Cochrane Database Syst Rev. 2022 Sep 1;9(9):CD002202. doi: 10.1002/14651858.CD002202.pub3.
5
Preoperative blood transfusions for sickle cell disease.镰状细胞病的术前输血
Cochrane Database Syst Rev. 2016 Apr 6;4(4):CD003149. doi: 10.1002/14651858.CD003149.pub3.
6
Red blood cell transfusion management for people undergoing cardiac surgery for congenital heart disease.先天性心脏病心脏手术患者的红细胞输血管理
Cochrane Database Syst Rev. 2025 Mar 19;3(3):CD009752. doi: 10.1002/14651858.CD009752.pub3.
7
Folate supplementation in people with sickle cell disease.镰状细胞病患者的叶酸补充
Cochrane Database Syst Rev. 2018 Mar 16;3(3):CD011130. doi: 10.1002/14651858.CD011130.pub3.
8
Automated monitoring compared to standard care for the early detection of sepsis in critically ill patients.与标准护理相比,自动监测用于危重症患者脓毒症的早期检测
Cochrane Database Syst Rev. 2018 Jun 25;6(6):CD012404. doi: 10.1002/14651858.CD012404.pub2.
9
Hydroxyurea (hydroxycarbamide) for sickle cell disease.羟基脲(羟基脲素)用于镰状细胞病。
Cochrane Database Syst Rev. 2017 Apr 20;4(4):CD002202. doi: 10.1002/14651858.CD002202.pub2.
10
Extracorporeal carbon dioxide removal for the treatment of acute hypoxaemic respiratory failure: the REST RCT.体外二氧化碳清除治疗急性低氧性呼吸衰竭:REST随机对照试验
Health Technol Assess. 2025 Jul;29(33):1-16. doi: 10.3310/GJDM0320.

本文引用的文献

1
The impact of aspirin use on outcomes in patients with inflammatory bowel disease: Insights from a national database.阿司匹林使用对炎症性肠病患者结局的影响:来自国家数据库的见解。
Int J Colorectal Dis. 2023 Dec 20;39(1):6. doi: 10.1007/s00384-023-04575-7.
2
Predictors of Hospital-related Outcomes of COVID-19 Infection in Patients With Inflammatory Bowel Disease in the Early Pandemic Phase: A Nationwide Inpatient Database Survey.疫情早期炎症性肠病患者新冠病毒感染的医院相关结局预测因素:一项全国住院患者数据库调查
Inflamm Bowel Dis. 2024 Aug 1;30(8):1334-1344. doi: 10.1093/ibd/izad200.
3
Impact of Aspirin Use on Outcomes in Patients With Hepatocellular Cancer: A Nationwide Analysis.
阿司匹林使用对肝细胞癌患者预后的影响:一项全国性分析。
World J Oncol. 2023 Jun;14(3):195-204. doi: 10.14740/wjon1601. Epub 2023 Jun 11.
4
Nationwide retrospective study of critically ill adults with sickle cell disease in France.法国危重症镰状细胞病成年患者的全国回顾性研究。
Sci Rep. 2021 Nov 30;11(1):23132. doi: 10.1038/s41598-021-02437-2.
5
Administrative data identify sickle cell disease: A critical review of approaches in U.S. health services research.利用行政数据识别镰状细胞病:美国卫生服务研究中方法的批判性回顾。
Pediatr Blood Cancer. 2020 Dec;67(12):e28703. doi: 10.1002/pbc.28703. Epub 2020 Sep 17.
6
Estimated Life Expectancy and Income of Patients With Sickle Cell Disease Compared With Those Without Sickle Cell Disease.估算患有镰状细胞病与不患有镰状细胞病患者的预期寿命和收入。
JAMA Netw Open. 2019 Nov 1;2(11):e1915374. doi: 10.1001/jamanetworkopen.2019.15374.
7
Sickle cell disease: Clinical presentation and management of a global health challenge.镰状细胞病:全球健康挑战的临床表现和管理。
Blood Rev. 2019 Sep;37:100580. doi: 10.1016/j.blre.2019.05.004. Epub 2019 May 20.
8
Risk factors for hospitalizations and readmissions among individuals with sickle cell disease: results of a U.S. survey study.镰状细胞病患者住院和再入院的风险因素:一项美国调查研究的结果
Hematology. 2019 Dec;24(1):189-198. doi: 10.1080/16078454.2018.1549801.
9
Pathophysiology of Sickle Cell Disease.镰状细胞病的病理生理学。
Annu Rev Pathol. 2019 Jan 24;14:263-292. doi: 10.1146/annurev-pathmechdis-012418-012838. Epub 2018 Oct 17.
10
Sickle cell disease.镰状细胞病。
Nat Rev Dis Primers. 2018 Mar 15;4:18010. doi: 10.1038/nrdp.2018.10.